Soluble HLA Technology as a Strategy to Evaluate the Impact of HLA Mismatches

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Kunze Schumacher, Heike ^a   Blasczyk, Rainer ^a   Bade Doeding, Christina ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; PEPTIDE; HLA ANTIGEN;

ALLELE; AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; BONE MARROW TRANSPLANTATION; ELUTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GRAFT VERSUS HOST REACTION; HLA MATCHING; IMMUNE RESPONSE; MASS SPECTROMETRY; REVIEW; T LYMPHOCYTE; TECHNOLOGY; BIOLOGICAL MODEL; GENETICS; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; PROCEDURES; UNRELATED DONORS;

ALLELES; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; MODELS, IMMUNOLOGICAL; PEPTIDES; T-LYMPHOCYTES; UNRELATED DONORS;

EID: 84931339232     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/246171     Document Type: Review

References (72)

1. S. J. Lee, J. Klein, M. Haagenson et al., "High-resolution donorrecipient HLA matching contributes to the success of unrelated donormarrow transplantation, " Blood, vol. 110, no. 13, pp. 4576-4583, 2007.
2. K. Fleischhauer, F. Locatelli, M. Zecca et al., "Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction, " Blood, vol. 107, no. 7, pp. 2984-2992, 2006.
3. E. Zino, L. Vago, S. Di Terlizzi et al., "Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation, " Biology of Blood andMarrow Transplantation, vol. 13, no. 9, pp. 1031-1040, 2007.
4. R. Crocchiolo, E. Zino, L. Vago et al., "Nonpermissive HLADPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation, " Blood, vol. 114, no. 7, pp. 1437-1444, 2009.
5. B. Mierzejewska, P.M. Schroder, C. E. Baum et al., "Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP, " Human Immunology, vol. 75, no. 8, pp. 703-708, 2014.
6. T. Zuckerman and J. M. Rowe, "Alternative donor transplantation in acute myeloid leukemia: which source and when?" Current Opinion in Hematology, vol. 14, no. 2, pp. 152-161, 2007.
7. E. W. Petersdorf, "Risk assessment in haematopoietic stem cell transplantation: histocompatibility, " Best Practice and Research: Clinical Haematology, vol. 20, no. 2, pp. 155-170, 2007.
8. E.W. Petersdorf, "Optimal HLAmatching in hematopoietic cell transplantation, " Current Opinion in Immunology, vol. 20, no. 5, pp. 588-593, 2008.
9. M. A. Fernandez-Vina, T. Wang, S. J. Lee et al., "Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation, " Blood, vol. 123, no. 8, pp. 1270-1278, 2014.
10. J. Pidala, T. Wang, M. Haagenson et al., "Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality, " Blood, vol. 122, no. 22, pp. 3651-3658, 2013.
11. T. Huyton, N. Ladas, H. Schumacher, R. Blasczyk, and C. Bade-Doeding, "Pocketcheck: updating the HLA class I peptide specificity roadmap, " Tissue Antigens, vol. 80, no. 3, pp. 239-248, 2012.
12. S. Badrinath, P. Saunders, T. Huyton et al., "Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen Bz.ast;44 allotypes, " Haematologica, vol. 97, no. 1, pp. 98-106, 2012.
13. D. Zernich, A. W. Purcell, W. A. Macdonald et al., "Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion, " Journal of Experimental Medicine, vol. 200, no. 1, pp. 13-24, 2004.
14. P. A. Wearsch and P. Cresswell, "The quality control of MHC class I peptide loading, " Current Opinion in Cell Biology, vol. 20, no. 6, pp. 624-631, 2008.
15. C. Bade-Doeding, T. Huyton, B. Eiz-Vesper, and R. Blasczyk, "The composition of the F pocket in HLA-A∗74 generates C-terminal promiscuity among its bound peptides, " Tissue Antigens, vol. 78, no. 5, pp. 378-381, 2011.
16. S. Badrinath, T. Huyton, H. Schumacher, R. Blasczyk, and C. Bade-Doeding, "Position 45 influences the peptide binding motif ofHLA-B∗44:08, " Immunogenetics, vol. 64, no. 3, pp. 245-249, 2012.
17. T. Huyton, H. Schumacher, R. Blasczyk, and C. Bade-Doeding, "Residue 81 confers a restricted C-terminal peptide binding motif inHLA-B∗44:09, " Immunogenetics, vol. 64, no. 9, pp.663-668, 2012.
18. K. R. Prilliman, D. Crawford, H. D. Hickman, K.W. Jackson, J. Wang, andW. H. Hildebrand, "Alpha-2 domain polymorphism and HLA class I peptide loading, " Tissue Antigens, vol. 54, no. 5, pp. 450-460, 1999.
19. F. E. Tynan, D. Elhassen, A. W. Purcell et al., "The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation, " Journal of ExperimentalMedicine, vol. 202, no. 9, pp. 1249-1260, 2005.
20. C. Bade-Döding, A. Theodossis, S. Gras et al., "The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B∗41 allotypic family, " Haematologica, vol. 96, no. 1, pp. 110-118, 2011.
21. K. Fleischhauer, N. A. Kernan, R. J. O'Reilly, B. Dupont, and S. Y. Yang, "Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44, " The New England Journal ofMedicine, vol. 323, no. 26, pp. 1818-1822, 1990.
22. K. Fleischhauer, D. Avila, F. Vilbois et al., "Characterization of natural peptide ligands for HLA-B∗4402 and-B∗4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain, " Tissue Antigens, vol. 44, no. 5, pp. 311-317, 1994.
23. W. A.Macdonald, A.W. Purcell, N. A.Mifsud et al., "A naturally selected dimorphismwithin theHLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition, " Journal of Experimental Medicine, vol. 198, no. 5, pp. 679-691, 2003.
24. J. Herman, V. Jongeneel, D. Kuznetsov, and P. G. Coulie, "Differences in the recognition by CTL of peptides presented by the HLA-B∗4402 and the HLA-B∗4403 molecules which differ by a single amino acid, " Tissue Antigens, vol. 53, no. 2, pp. 111-121, 1999.
25. M. Hirosawa, M. Hoshida, M. Ishikawa, and T. Toya, "MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming, " Computer Applications in the Biosciences, vol. 9, no. 2, pp. 161-167, 1993.
26. K. Falk, O. Rotzschke, S. Stevanovic et al., "Allele-specificmotifs revealed by sequencing of self-peptides eluted from MHC molecules, " Nature, vol. 351, no. 6324, pp. 290-296, 1991.
27. R. T. Kubo, A. Sette, H. M. Grey et al., "Definition of specific peptide motifs for four major HLA-A alleles, " Journal of Immunology, vol. 152, no. 8, pp. 3913-3924, 1994.
28. R. Maier, K. Falk, O. Rotzschke et al., "Peptide motifs of HLAA3,-A24, and-B7molecules as determined by pool sequencing, " Immunogenetics, vol. 40, no. 4, pp. 306-308, 1994.
29. M. DiBrino, K. C. Parker, J. Shiloach et al., "Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8, " Journal of Immunology, vol. 152, no. 2, pp. 620-631, 1994.
30. T. Sudo, N. Kamikawaji, A. Kimura et al., "Differences in MHC class I self peptide repertoires among HLA-A2 subtypes, " The Journal of Immunology, vol. 155, no. 10, pp. 4749-4756, 1995.
31. P. Krausa, C. Münz, W. Keilholz et al., "Definition of peptide binding motifs amongst the HLA-A∗30 allelic group, " Tissue Antigens, vol. 56, no. 1, pp. 10-18, 2000.
32. K. R. Prilliman, K. W. Jackson, M. Lindsey, J. Wang, D. Crawford, and W. H. Hildebrand, "HLA-B15 peptide ligands are preferentially anchored at their C termini, " Journal of Immunology, vol. 162, no. 12, pp. 7277-7284, 1999.
33. C. Bade-Doeding, D. S. DeLuca, A. Seltsam, R. Blasczyk, and B. Eiz-Vesper, "Amino acid 95 causes strong alteration of peptide position Pω in HLA-B∗41 variants, " Immunogenetics, vol. 59, no. 4, pp. 253-259, 2007.
34. S. Badrinath, T. Huyton, H. Kunze-Schumacher, H. Andreas Elsner, R. Blasczyk, and C. Bade-Doeding, "Differential impact of HLA-B∗44 allelic mismaches at position 156 on peptide binding specificities and T-cell diversity, " Journal of Stem Cell Research &Therapy, vol. 4, no. 4, 2014.
35. C. Bade-Doeding, P. Cano, T. Huyton et al., "Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B∗44:02P, " Human Immunology, vol. 72, no. 11, pp. 1039-1044, 2011.
36. F. Bettens, U. Schanz, and J. M. Tiercy, "Lack of recognition of HLA class I mismatches outside α1/α2 domains by CD8+ alloreactive T lymphocytes: the HLA-B44 paradigm, " Tissue Antigens, vol. 81, no. 6, pp. 414-418, 2013.
37. P. T. Illing, J. P. Vivian, N. L. Dudek et al., "Immune selfreactivity triggered by drug-modified HLA-peptide repertoire, " Nature, vol. 486, no. 7404, pp. 554-558, 2012.
38. K. E. Scull, N. L. Dudek, A. J. Corbett et al., "Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A∗02:01 ligands, " Molecular Immunology, vol. 51, no. 2, pp. 136-142, 2012.
39. C. J. Barnstable, W. F. Bodmer, G. Brown et al., "Production of monoclonal antibodies to groupAerythrocytes, HLAand other human cell surface antigens-newtools for genetic analysis, " Cell, vol. 14, no. 1, pp. 9-20, 1978.
40. F. M. Brodsky, P. Parham, and C. J. Barnstable, "Monoclonal antibodies for analysis of the HLA system, " Immunological Reviews, vol. 47, pp. 3-61, 1979.
41. Y. Kim, J. Sidney, C. Pinilla, A. Sette, and B. Peters, "Derivation of an amino acid similarity matrix for peptide:MHC binding and its application as a Bayesian prior, "BMC Bioinformatics, vol. 10, article 394, 2009.
42. H. Mamitsuka, "Predicting peptides that bind to MHC molecules using supervised learning of hiddenMarkovmodels, " Proteins, vol. 33, no. 4, pp. 460-474, 1998.
43. M. Nielsen and O. Lund, "NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction, " BMC Bioinformatics, vol. 10, article 296, 2009.
44. C. Zhang, M. G. Bickis, F. Wu, and A. J. Kusalik, "Optimallyconnected Hidden Markov models for predicting MHCbinding peptides, " Journal of Bioinformatics and Computational Biology, vol. 4, no. 5, pp. 959-980, 2006.
45. Y. Zhao, B. Gran, C. Pinilla et al., "Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands, " Journal of Immunology, vol. 167, no. 4, pp. 2130-2141, 2001.
46. H.Rammensee, J.Bachmann, N. P.N. Emmerich, O. A. Bachor, and S. Stevanovíc, "SYFPEITHI: database forMHC ligands and peptide motifs, " Immunogenetics, vol. 50, no. 3-4, pp. 213-219, 1999.
47. M. M. Schuler, M. Nastke, and S. Stevanovikć, "SYFPEITHI: database for searching and T-cell epitope prediction, " Methods in Molecular Biology, vol. 409, pp. 75-93, 2007.
48. C. Lundegaard, K. Lamberth, M. Harndahl, S. Buus, O. Lund, and M. Nielsen, "NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11, " Nucleic Acids Research, vol. 36, pp. W509-W512, 2008.
49. P.A.Reche, J.Glutting, H. Zhang, andE.L.Reinherz, "Enhancement to the RANKPEP resource for the prediction of peptide binding toMHCmolecules using profiles, " Immunogenetics, vol. 56, no. 6, pp. 405-419, 2004.
50. D. S. DeLuca and R. Blasczyk, "Implementing the modular MHCmodel for predicting peptide binding, " Methods inMolecular Biology, vol. 409, pp. 261-271, 2007.
51. K. C. Parker, M. A. Bednarek, and J. E. Coligan, "Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains, " The Journal of Immunology, vol. 152, no. 1, pp. 163-175, 1994.
52. J. J. Miles, D. Elhassen, N. A. Borg et al., "CTL recognition of a bulged viral peptide involves biased TCR selection, " The Journal of Immunology, vol. 175, no. 6, pp. 3826-3834, 2005.
53. F. E. Tynan, N. A. Borg, J. J. Miles et al., "High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I: implications for T-cell receptor engagement and T-cell immunodominance, " The Journal of Biological Chemistry, vol. 280, no. 25, pp. 23900-23909, 2005.
54. F. E. Tynan, H. H. Reid, L. Kjer-Nielsen et al., "A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule, " Nature Immunology, vol. 8, no. 3, pp. 268-276, 2007.
55. S. R. Burrows, J. Rossjohn, and J. McCluskey, "Have we cut ourselves too short in mapping CTL epitopes?" Trends in Immunology, vol. 27, no. 1, pp. 11-16, 2006.
56. K. J. Green, J. J. Miles, J. Tellam, W. J. M. van Zuylen, G. Connolly, and S. R. Burrows, "Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length, " European Journal of Immunology, vol. 34, no. 9, pp. 2510-2519, 2004.
57. F. E. Tynan, S. R. Burrows, A. M. Buckle et al., "T cell receptor recognition of a "super-bulged" major histocompatibility complex class I-bound peptide, " Nature Immunology, vol. 6, no. 11, pp. 1114-1122, 2005.
58. M. J. Bell, J. M. Burrows, R. Brennan et al., "The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length, " Molecular Immunology, vol. 46, no. 8-9, pp. 1911-1917, 2009.
59. M. J. Rist, A. Theodossis, N. P. Croft et al., "HLA peptide length preferences control CD8+ T cell responses, " The Journal of Immunology, vol. 191, no. 2, pp. 561-571, 2013.
60. M. Ghei, D. F. Stroncek, and M. Provenzano, "Analysis of memory T lymphocyte activity following stimulationwith overlapping HLA-A∗2402, A∗0101 and Cw∗0402 restricted CMV pp65 peptides, " Journal of Translational Medicine, vol. 3, article 23, 2005.
61. S. Matsumura, H. Kita, X. He et al., "Comprehensive mapping of HLA-A0201-restricted CD8 T-cell epitopes on PDC-E2 in primary biliary cirrhosis, " Hepatology, vol. 36, no. 5, pp. 1125-1134, 2002.
62. S. L. Slezak, M. Bettinotti, S. Selleri, S. Adams, F. M.Marincola, and D. F. Stroncek, "CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects, " Journal of Translational Medicine, vol. 5, article 17, 2007.
63. H.-A. Elsner, D.DeLuca, J. Strub, and R. Blasczyk, "HistoCheck: rating of HLA class I and II mismatches by an internet-based software tool, " Bone Marrow Transplantation, vol. 33, no. 2, pp. 165-169, 2004.
64. M. A. Saper, P. J. Bjorkman, and D. C.Wiley, "Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 °A resolution, " Journal ofMolecular Biology, vol. 219, no. 2, pp. 277-319, 1991.
65. G. Chelvanayagam, "A roadmap for HLA-A, HLA-B, and HLAC peptide binding specificities, " Immunogenetics, vol. 45, no. 1, pp. 15-26, 1996.
66. S. Buus, S. L. Lauemøller, P.Worning et al., "Sensitive quantitative predictions of peptide-MHC binding by a "Query by Committee" artificial neural network approach, " Tissue Antigens, vol. 62, no. 5, pp. 378-384, 2003.
67. S. Carrasco Pro, M. Zimic, and M. Nielsen, "Improved panspecific MHC class I peptide-binding predictions using a novel representation of the MHC-binding cleft environment, " Tissue Antigens, vol. 83, no. 2, pp. 94-100, 2014.
68. D. S. DeLuca, B. Khattab, and R. Blasczyk, "A modular concept of HLA for comprehensive peptide binding prediction, " Immunogenetics, vol. 59, no. 1, pp. 25-35, 2007.
69. W. W. P. Liao and J. W. Arthur, "Predicting peptide binding to Major Histocompatibility Complex molecules, " Autoimmunity Reviews, vol. 10, no. 8, pp. 469-473, 2011.
70. D.Rognan, S. L. Lauemøller, A.Holm, S. Buus, andV. Tschinke, "Predicting binding affinities of protein ligands from threedimensional models: Application to peptide binding to class I major histocompatibility proteins, " Journal of Medicinal Chemistry, vol. 42, no. 22, pp. 4650-4658, 1999.
71. D. Rognan, "Molecular dynamics simulation of MHC-peptide complexes as a tool for predicting potential T cell epitopes, " Biochemistry, vol. 33, no. 38, pp. 11476-11485, 1994.
72. E.W. Petersdorf, M.Malkki, K. Hsu et al., "16th IHIW: international histocompatibility working group in hematopoietic cell transplantation, " International Journal of Immunogenetics, vol. 40, no. 1, pp. 2-10, 2013.